Inventor

HUGHES ADAM D

US101 patents

⚠️ This page may combine multiple inventors who share the name “HUGHES ADAM D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HUGHES ADAM D

THERAVANCE BIOPHARMA R&D IP LLC

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Neprilysin inhibitors

Neprilysin inhibitors

(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Neprilysin inhibitors

Neprilysin inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Neprilysin inhibitors

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

HUGHES ADAM D

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

FLEURY MELISSA

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

THERAVANCE RESPIRATORY CO LLC

Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

GENDRON ROLAND

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

THERAVANCE INC

Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Neprilysin inhibitors

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

MAMMEN MATHAI

Nitric oxide donor neprilysin inhibitors

Biphenyl derivatives

FENSTER ERIK

Neprilysin inhibitors

Neprilysin inhibitors

SMITH CAMERON

Neprilysin inhibitors

COLSON PIERRE-JEAN

Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity